Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-09-22-Speech-3-971"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2010-09-22"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"de"^^xsd:language2
lpv:document identification number	"en.20100922.20.3-971"2
lpv:hasSubsequent	lp_eu:2010-09-22-Speech-3-9702
lpv:speaker	lp:Andreas Mölzer2
lpv:spokenAs	substitute; AFCO (2009-07-16--2012-01-18)3 member; NA (2009-07-14--2014-06-30)3 member; AFET (2009-07-16--2012-01-18)3 member; Delegation to the EU-Ukraine Parliamentary Cooperation Committee (2009-09-16--2014-06-30)3 unknown; Freiheitliche Partei Österreichs (2009-07-14--2014-06-30)3 substitute; Delegation to the EU-Chile Joint Parliamentary Committee (2009-09-16--2014-06-30)3
lpv:translated text	"The health of the population is a key political concern and it should remain so, too. Pharmaceutical firms bring a large number of new life- and health-improving medicines onto the market every year. According to the rapporteur, an estimated 197 000 people die each year as a result of Adverse Drug Reactions (ADRs) to such medicines. As a matter of urgency, we ought to carry out a very thorough review of the authorisation of new medicines and examine detailed information on ADRs as quickly as possible. In addition, it ought to be made possible for patients themselves, in an uncomplicated manner, to provide a report not only to the pharmaceutical companies, but also to national institutions. I voted in favour of the report, as the new regulations are, in my view, sufficient to guarantee the safety of patients."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph